In Silico Modeling of Non-Linear Drug Absorption for the P-gp Substrate Talinolol and of Consequences for the Resulting Pharmacodynamic Effect

Publication: AAPS J
Software: GastroPlus®
Division: Simulations Plus

Purpose

The aim of the present work was to demonstrate P-glycoprotein’s involvement in the non-linear talinolol pharmacokinetics using an advanced compartment and transit model (ACAT) and to compare the results predicted from the model to the finding of a phase I dose escalation study with oral talinolol doses increasing from 25 to 400 mg.

By Michael B Bolger